Shionogi targets JPY550B revenue through QOL focus and global expansion
Management reiterated its full-year revenue target of JPY460 billion and emphasized achieving JPY550 billion in FY2025. Growth is expected from the HIV franchise, global expansion of Xocova, and ...
US health agencies scrub HIV, other data to remove 'gender ideology'
The U.S. Centers for Disease Control and Prevention and other federal health agencies on Friday took down webpages with ...
US restores crucial HIV treatment access for millions as South African organisations voice funding fears
The decision, made by US Secretary of State Marco Rubio, enables individuals in 55 countries, including South Africa, to receive uninterrupted access to US-funded HIV treatment, a ...
EU approves first long-acting HIV treatment for teens
LONDON - The European Commission has authorized the use of Vocabria and Rekambys, a long-acting injectable regimen, for adolescents living with HIV-1, ViiV Healthcare, majority-owned by GSK (NYSE: GSK ...
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...
Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial
HOOKIPA Pharma (HOOK) announced that enrollment is complete in the Phase 1b clinical trial evaluating HB-500 for the treatment of HIV, with 30 ...
The Street Journal4d
A cure for HIV: ‘One of the hardest goals in science’
HIV is "like a time bomb," said James Riley, a microbiologist at University of Pennsylvania, US. Even now — decades after the virus was identified — and with antiretroviral drugs allowing us to ...
NanoViricides Engages CRO for Phase II Clinical Trial
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
MedPage Today9d
HIV/AIDS
Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...
The American Journal of Managed Care10d
Combination of Dolutegravir, Lamivudine Effective in People Living With HIV
Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, ...
verywellhealth16d
How Long Does It Take for HIV to Turn Into AIDS?
This occurs in only 1% to 5% of HIV infections as people remain asymptomatic and the virus levels stay low. Stages of HIV Infection The stages of infection from person to person vary slightly, both in ...
The Raw Story16d
'Engine of retribution': Analyst says SCOTUS case could tee up Trump to wreck HIV care
Matthew Chapman is a video game designer who attended Rensselaer Polytechnic Institute and lives in San Marcos, Texas. Before joining Raw Story, he wrote for Shareblue and AlterNet, specializing ...